🦷 General Care
✨ Treatments
👶 Family Care
💚 Wellness
💡 Resources

When it comes to treating damaged dental pulp in children’s teeth, we’ve come a long way from the days when extraction was the default solution. Today’s pediatric dentistry embraces a more conservative approach, focusing on preserving natural teeth whenever possible. At the forefront of this evolution are bioactive materials—revolutionary substances that don’t just fill space but actively participate in the healing process.
As someone passionate about dental health education, I’m excited to share how these materials are transforming pediatric pulp therapy and improving outcomes for our youngest patients. Let’s explore the science, clinical applications, and future directions of this fascinating field.
Traditional dental materials like amalgam, composite resins, and even some cements act primarily as passive fillers. They occupy space and provide structural support but don’t interact meaningfully with the surrounding tissues.
Bioactive materials, in contrast, actively engage with the biological environment. Dr. Sarah Johnson, pediatric endodontist at Children’s Dental Research Institute, explains: “These materials don’t just sit there—they communicate with the surrounding tissues, releasing beneficial ions, stimulating cellular responses, and promoting healing.”
The key characteristics that make a dental material “bioactive” include:
For decades, calcium hydroxide (CH) was the gold standard for pulp capping and pulpotomy procedures. While revolutionary for its time, CH has limitations, including:
The search for better alternatives led to the development of calcium silicate-based materials, which have dramatically improved outcomes in pediatric pulp therapy.
Often considered the first true game-changer in bioactive dental materials, MTA was approved by the FDA in 1997 and remains a benchmark against which newer materials are compared.
Composition: Primarily tricalcium silicate, dicalcium silicate, tricalcium aluminate, and bismuth oxide
Mechanism of Action:
Clinical Success:
Limitations:
Introduced as a “dentin substitute,” Biodentine has gained popularity for its improved handling characteristics and faster setting time compared to MTA.
Composition: 80.1% tricalcium silicate with added calcium carbonate, zirconium oxide, and a water-based liquid containing calcium chloride
Mechanism of Action:
Clinical Success: A 2025 study in the Journal of Clinical Pediatric Dentistry reported impressive success rates for Biodentine:
Advantages Over MTA:
Dr. Michael Chen, researcher at Nature Scientific Reports, notes: “Biodentine has emerged as a viable alternative to MTA, offering comparable success rates with some practical advantages that make it particularly suitable for pediatric applications.”
A unique light-curable resin-modified calcium silicate material, TheraCal LC combines the benefits of calcium silicate with the convenience of light-curing.
Composition: Calcium silicates in a resin matrix (45% calcium silicate, 10% radiopaque component, 5% hydrophilic thickening agent, and 45% resin)
Mechanism of Action:
Clinical Applications:
Considerations:
Newer entries in the calcium silicate family, these materials aim to address some limitations of traditional MTA.
Composition: Refined calcium silicate formula without the bismuth oxide found in traditional MTA
Key Features:
Clinical Performance: A March 2025 study comparing bioactive materials in indirect pulp therapy found:
For deep caries approaching the pulp but without exposure, bioactive materials serve as protective liners that:
When small pulp exposures (≤1mm) occur during caries removal or due to trauma:
For larger pulp exposures or symptoms of reversible pulpitis:
Dr. Lisa Wong, pediatric dentist at Biodentine Research Institute, shares: “A study indicated that full pulpotomy using Biodentine in cases of irreversible pulpitis achieved a clinical success rate of 98.4% at 6 months, increasing to 100% at 12 months. These are remarkable outcomes that were unimaginable with previous materials.”
For immature permanent teeth with pulp necrosis, bioactive materials play a crucial role in:
The remarkable outcomes achieved with bioactive materials can be attributed to several key mechanisms:
Calcium and hydroxyl ions released from these materials:
Bioactive materials influence cellular behavior by:
The high pH environment created by materials like MTA and Biodentine:
The interaction between bioactive materials and dentin creates:
The field continues to evolve rapidly, with several exciting developments on the horizon:
Researchers are developing improved delivery mechanisms for bioactive materials:
The integration of bioactive materials with tissue engineering principles is opening new possibilities:
According to a 2024 study in Bioactive Materials, “Modified dental pulp stem cells (MDPSCs) can promote blood vessel formation and dental pulp tissue regeneration more effectively when combined with growth factors and appropriate bioactive scaffolds.”
The concept of bioactivity is extending beyond pulp therapy to restorative materials:
The next generation of bioactive materials may include “smart” features:
The advancements in bioactive materials translate to several important benefits for pediatric patients:
With materials that actively promote healing, dentists can:
The superior performance of bioactive materials means:
Modern bioactive materials contribute to a better patient experience through:
By successfully preserving primary teeth, bioactive materials help:
When selecting bioactive materials for pediatric pulp therapy, several factors should be considered:
While bioactive materials often have higher initial costs, Dr. Robert Wilson, pediatric dental researcher, puts it in perspective: “When you consider the reduced need for retreatment, fewer complications, and better long-term outcomes, the investment in quality bioactive materials is easily justified.”
The evolution of bioactive materials represents one of the most significant advances in pediatric dentistry in recent decades. These materials have transformed our approach to pulp therapy, allowing us to preserve natural teeth with unprecedented success rates.
As research continues and new materials emerge, we can expect even better outcomes for children requiring pulp therapy. The trend toward materials that not only repair but actively regenerate dental tissues holds particular promise for the future.
For parents, these advancements mean that a diagnosis of deep decay or pulp exposure in their child’s tooth is no longer a cause for despair. With modern bioactive materials, the prognosis for saving these teeth—and maintaining their natural function until they’re ready to exfoliate—is better than ever before.
The field of bioactive materials in pediatric pulp therapy stands as a testament to how science and clinical practice can come together to improve children’s oral health, one tooth at a time.
Have questions about bioactive materials or pulp therapy for your child? Share them in the comments below, and we’ll address them in a future post!